However, UNG-silencing in combination with DUTi significantly increased cancer cell lethality when used in combination with FUdR or epirubicin (Fig. 5C) and significantly increased growth inhibition with DUTi in combination with FUdR (Fig. 5A, B). Here, UNG is linked to cancer.